2019 Interactive Breakout Discussions

Tuesday, February 19

BREAKOUT DISCUSSION GROUPS

4:10 Find Your Table and Meet Your Moderator

4:15 Interactive Breakout Discussion Groups

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

5:00 Welcome Reception in the Exhibit Hall

6:30 Close of Day


We are currently building the agendas for SCOPE 2019 and the topics and co-moderators for the breakout discussion groups will be posted later. Below are some examples from the 2018 program.

TABLE 1: What Is Holding Back the Adoption of eConsent?

TABLE 2: Embracing Best Practices in Protocol Design to Reduce Protocol Amendments and Improve Trials

TABLE 3: Coordinating Contracting and Payments to Enhance Efficiencies

TABLE 4: Barriers and Opportunities in Site Adoption of Clinical Trial Technology

TABLE 5: Strategies for Accelerating Recruitment in Complex Clinical Trials in a Resource Constrained Environment

TABLE 6: Precision Feasibility in Precision Medicine-Driven Trials

TABLE 7: Optimizing Country and Site Selection: Strategies for Positioning Trials for Success Using a Global Footprint

TABLE 8: Improving Both Time and Quality in Site Activation and Study Start-Up

TABLE 9: Strategies for Patient-Centric Trial Design and Digital Patient Engagement

TABLE 10: Balancing Budgets and Performance in Resource Management and Capacity Planning

TABLE 11: RBM in a Finance and Resource Limited Environment

TABLE 12: Vendor Performance Metrics and KPIs

TABLE 13: Understanding and Implementing the New Reality of Diversity in Clinical Trials

TABLE 14: Selecting, Developing and Incorporating Novel Endpoints, Generated from Data Captured by Mobile Technologies, for Use in Clinical Trials

TABLE 15: RWE in Clinical Trial Research and Patient Recruitment

TABLE 16: Visual Analytics in Clinical Research

TABLE 17: Addressing Chronic Site and CRA Turnover Issues through a Competency-Based Approach to Workforce Development

TABLE 18: Biospecimen, Central Lab and Technology

TABLE 19: Artificial Intelligence and Machine Learning: Extreme Case of Data Analytics?

TABLE 20: Blurring the Division between Clinical and Observational Studies

TABLE 21: Driving Fully eSource Clinical Trial

 



Premier Sponsors

Appian

Bioclinica_new

ClinicalInk

Covance

DrugDev

ERT

PRA Health Sciences

Praxis

Syneos Health

UBC

Veeva